Valeo Pharmainc (VPH.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.660 unch (unch) 03/28/22 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.660 unch (unch) -
Fiscal Year End Date: 10/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 258 | 244 | 206 | 150 | 143 |
| Accounts receivable | -104 | 1,041 | -1,059 | -878 | 313 |
| Other Working Capital | -4,450 | 3,990 | -3,127 | -335 | -1,397 |
| Other Operating Activity | -4,757 | -7,804 | -1,517 | -530 | -1,755 |
| Operating Cash Flow | $-9,053 | $-2,529 | $-5,497 | $-1,593 | $-2,696 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -139 | -645 | -213 | -14 | -30 |
| Purchase Sale Intangibles | -18 | -517 | 100 | -2,060 | -86 |
| Other Investing Activity | 0 | 0 | 100 | 0 | 0 |
| Investing Cash Flow | $-157 | $-1,162 | $-113 | $-2,074 | $-116 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 405 | 0 | 6,645 | 0 |
| Debt Repayment | -4,297 | -4,873 | -244 | -195 | -24 |
| Common Stock Issued | N/A | 3,040 | 9,444 | N/A | 735 |
| Other Financing Activity | -1,466 | -1,814 | 1,748 | 235 | 2 |
| Financing Cash Flow | $19,237 | $-3,242 | $10,948 | $6,685 | $713 |
| Exchange Rate Effect | 23 | -13 | 1 | -85 | -20 |
| Beginning Cash Position | 2,043 | 8,986 | 3,650 | 717 | 2,836 |
| End Cash Position | 12,093 | 2,043 | 8,989 | 3,650 | 717 |
| Net Cash Flow | $10,027 | $-6,930 | $5,338 | $3,018 | $-2,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,053 | -2,529 | -5,497 | -1,593 | -2,696 |
| Capital Expenditure | -157 | -1,162 | -213 | -2,074 | -116 |
| Free Cash Flow | -9,210 | -3,691 | -5,710 | -3,667 | -2,812 |